Brightview Psychiatry Solutions
Secondary Service Connection

GERD secondary to NSAID use

Most write-ups on this claim argue that NSAIDs relax the valve at the bottom of the esophagus. The controlled evidence does not support that, and an examiner who knows it will discard the whole opinion. The stronger argument is a different one — and it happens to be the argument that lines up with what the VA now actually rates.

Veteran at a kitchen table holding his chest in discomfort beside bottles of ibuprofen and naproxen
Written by Robert J. Allen, Jr., M.D. — board certified in Physical Medicine and Rehabilitation, fellowship trained in Pain Medicine, and a former VA Compensation & Pension examiner. · Last reviewed September 1, 2026.

Direct answer

Can GERD be secondary to NSAIDs taken for a service-connected condition?

Yes. Under 38 C.F.R. § 3.310, a disability caused or aggravated by treatment for a service-connected condition can itself be service-connected. If the VA rated your back, neck, knee, shoulder, hip, arthritis, radiculopathy, or migraine condition, and NSAIDs were the treatment for it, then the medication is part of the service-connected disability picture rather than something separate from it.

  1. 1A service-connected painful conditionDegenerative disc disease, a rated spine or joint disability, arthritis, radiculopathy, or a migraine disorder.
  2. 2Long-term NSAID treatment for itPrescribed, recommended, or bought over the counter — often for a decade or more.
  3. 3Gastric and esophageal mucosal injuryLoss of prostaglandin-dependent mucosal defenses, plus direct contact injury to the esophageal lining.
  4. 4Reflux disease that develops or worsensEsophagitis, erosions, ulceration, and in some veterans, stricture.

Common NSAIDs are ibuprofen (Motrin, Advil), naproxen (Aleve, Naprosyn), meloxicam (Mobic), diclofenac (Voltaren), celecoxib (Celebrex), indomethacin (Indocin), and aspirin.

But the question that decides these claims is almost never "do NSAIDs cause GERD." It is narrower and more factual than that: what did this veteran take, for how long, why was it necessary, when did the reflux start, and did the esophagus sustain injury that shows up on an endoscopy. An opinion that answers those five questions is doing something a generic literature summary is not.

Before anything else: nothing here is guidance about your own medication. Do not start, stop, or change an NSAID, an aspirin regimen, or a reflux medication because of a VA claim or because of something you read on a website. Aspirin in particular is often prescribed for cardiac reasons, and stopping it carries real risk. A claim is built from the record as it already exists.

Ask whether this pathway fits your record

Send your rating decision, medication list, and any endoscopy report.

Who writes this opinion

Why does it matter that a pain physician writes this letter?

Because half of this claim is not a gastrointestinal question at all.

The reflux is the downstream condition. The claim actually turns on the upstream one — whether the service-connected disability was severe enough to require years of anti-inflammatory treatment, whether that treatment was reasonable, what doses were involved, and why nothing else was used instead. That is a pain medicine and musculoskeletal question, and it is the part a gastroenterology-flavored opinion tends to skip.

Robert J. Allen, Jr., M.D.

Board certified in Physical Medicine and Rehabilitation · Fellowship trained in Pain Medicine · Former VA Compensation and Pension examiner

RJA Consulting PLLC

A graduate of the University of Connecticut School of Medicine, with residency and fellowship training at Eastern Virginia Medical School. In private practice since 2012 and, beginning in 2016, performed thousands of VA compensation and pension examinations as an independent examiner retained by VES, QTC, and Optum Serve. He no longer conducts examinations for VA contractors and now writes independent medical opinions only. Earlier in his career he worked at the VA Medical Center in Hampton, Virginia and the Naval Medical Center in Portsmouth.

The conditions that put veterans on long-term NSAIDs are the conditions he spent a career evaluating and treating:

  • Lumbar and cervical spine disease, degenerative disc disease, and post-surgical spine pain
  • Knee, hip, shoulder, elbow, wrist, ankle, and foot disabilities
  • Degenerative and inflammatory arthritis
  • Radiculopathy and other painful neurologic conditions
  • Traumatic injuries and chronic musculoskeletal pain
  • Headache and migraine disorders requiring analgesic treatment
Best fit when: the anchor disability is musculoskeletal, orthopedic, neurologic, or a headache disorder, and the medication at issue is an analgesic or anti-inflammatory.

For a GERD claim, that means the opinion can address the whole chain in one voice — why the anti-inflammatory was medically necessary for the rated disability, what exposure it produced, and what that exposure did to the esophagus — instead of treating a veteran's pain history and their reflux history as two unrelated medical stories that happen to share a chart.

Where the anchor condition is psychiatric instead — reflux claimed secondary to PTSD, anxiety, or a psychotropic medication — that is a different pathway and a different physician. See GERD secondary to anxiety and PTSD, written by Dr. Jessica R. Allen. Veterans who are rated for both a pain condition and a psychiatric condition are common, and the consultation will sort out which opinion the file actually needs.

The mechanism

How do NSAIDs actually damage the esophagus?

Not the way most veteran-facing websites say they do. Being precise here is what makes the opinion survive review.

What the evidence supports

NSAIDs block cyclooxygenase, which is how they relieve pain — and the same blockade reduces the prostaglandins that maintain the protective mucus layer, bicarbonate secretion, and mucosal blood flow throughout the upper gastrointestinal tract. That is the best-established injury mechanism in medicine for these drugs, and it is why NSAID gastropathy, erosions, and ulcers are so well documented.

There is a second, more direct mechanism specific to the esophagus. NSAIDs are weak acids. In an acidic environment they cross into mucosal cells and cause local injury on contact, which is why pill-induced esophagitis is a recognized clinical entity associated with these drugs, particularly when a tablet is taken with little water or shortly before lying down. Laboratory work on esophageal tissue has shown that ibuprofen and aspirin impair the barrier function of the esophageal lining in a dose-dependent way, and that the damage from the drug and the damage from acid are additive — each one makes the other worse.

What the evidence shows epidemiologically

A national survey of nearly 7,000 adults found reflux symptoms in 27 percent of NSAID users compared with 19 percent of non-users, with NSAID use an independent predictor after adjustment. A Medicaid cohort study found roughly twice the risk of developing GERD among patients who had filled NSAID prescriptions. And in a study of nearly 14,000 patients who underwent endoscopy, NSAID use was an independent predictor of reflux esophagitis even after accounting for obesity, hiatal hernia, smoking, alcohol, and diabetes.

What the evidence does not support

A randomized, double-blind, placebo-controlled crossover study gave healthy volunteers naproxen 500 mg twice daily for a week and measured them with manometry and 24-hour pH monitoring. Acid exposure time did not increase. Lower esophageal sphincter pressure did not fall. Transient sphincter relaxations did not increase. In healthy young subjects with a normal esophagus, naproxen did not create reflux.

An opinion that leads with "NSAIDs relax the lower esophageal sphincter" is asserting the one thing that study specifically failed to find. It is the sort of claim a well-prepared reviewer can dismantle in a sentence, and it takes the rest of the letter down with it.

The argument most opinions miss

What did that negative study actually find?

This is the part worth slowing down for, because the study usually cited against these claims contains the strongest point in favor of them.

Nine healthy volunteers, aged 23 to 34, with normal esophageal function. As a group, nothing happened. But one subject was different at baseline — low sphincter pressure and already-elevated acid exposure, without symptoms. On naproxen, that subject's reflux increased markedly. Months later, that person developed symptomatic gastroesophageal reflux disease. The authors concluded that the effect of NSAIDs on people with a propensity to reflux deserves further study.

That is not a footnote. That is the entire claim, described in a single case.

NSAIDs are weak at creating reflux in a healthy esophagus, and considerably more relevant to an esophagus that is already refluxing.

They do not appear to break the anti-reflux barrier in someone who has none of the risk factors. What they do is remove the mucosal defenses of a lining that is being bathed in acid, and add direct chemical injury on top of it.

Which is why the median veteran in this situation is not someone whose reflux appeared from nowhere. It is someone in their forties or fifties, carrying some extra weight, maybe a hiatal hernia they have never been told about, with the occasional bout of heartburn — who then spends a decade on prescription-strength ibuprofen for a rated spine condition and ends up on daily omeprazole with erosive changes on endoscopy.

For that veteran, causation is the weaker theory and aggravation is the stronger one. Most opinions in this area argue only causation, and lose everything the moment the examiner finds a heartburn complaint that predates the prescription. An opinion that argues both does not have that vulnerability.

Does this look familiar?

You are service-connected for your back, neck, knees, shoulders, arthritis, or migraines. You have taken Motrin, ibuprofen, naproxen, meloxicam, diclofenac, or Celebrex for years — some of it prescribed, some of it off the shelf. Somewhere in there, heartburn stopped being occasional. Now there is an omeprazole or pantoprazole on your medication list, and you have stopped thinking of it as connected to anything.

If you have never looked at those two histories side by side, the medication record is worth reviewing before you file.

The evidence differs by drug

Which NSAIDs matter in this claim?

All of them carry the mechanism. What separates a strong file from a weak one is not which drug appears in the chart but how much of it, for how long, and why.

MedicationCommon namesTypically prescribed for
IbuprofenMotrin, AdvilMusculoskeletal pain, arthritis, headache — the single most common exposure in these files, prescribed at 600 to 800 mg three times daily
NaproxenAleve, NaprosynChronic arthritis and spine pain; long half-life means longer daily exposure
MeloxicamMobicOsteoarthritis and inflammatory arthritis; once-daily dosing often continued for years
DiclofenacVoltaren, CataflamArthritis and localized musculoskeletal pain; oral and topical forms differ substantially in systemic exposure
CelecoxibCelebrexArthritis where gastric risk was already a concern; COX-2 selective, with a different upper-GI risk profile that an opinion should acknowledge rather than ignore
IndomethacinIndocinGout, ankylosing spondylitis, certain headache disorders; among the more gastrotoxic agents
AspirinASA, Ecotrin, BufferinPain, and separately for cardiac prophylaxis; a low-dose cardiac aspirin is a genuinely different exposure from analgesic-dose aspirin, and conflating the two weakens an opinion

Educational summary. A medication belongs in the argument only if the veteran actually took it, at a meaningful dose, for long enough, at a time that fits the symptom chronology.

Three things carry more weight than the drug name: duration, because a decade of exposure is a different biological argument than six weeks; dose, because prescription-strength anti-inflammatory therapy is not the same as occasional over-the-counter use; and medical necessity, because a rating decision granting the underlying disability is the VA's own documentation that the treatment was needed.

The § 3.310 treatment pathway is not specific to GERD. The same regulation supports hemorrhoids secondary to opioid pain medication, urinary frequency secondary to blood pressure medication, and depression secondary to medication. It also reaches further down a chain of service-connected conditions, where the disability requiring the NSAID was itself granted as a secondary.

The over-the-counter problem

What if I bought my ibuprofen or Aleve over the counter?

This is the most common obstacle in these files, and it is usually solvable.

Years of over-the-counter ibuprofen and naproxen leave no trace in a VA pharmacy record. A rating decision can grant a knee disability, a veteran can take four Advil a day for eleven years, and the claims file will show no NSAID exposure at all. Examiners then note the absence and treat it as an absence of exposure, which are not the same thing.

What actually helps:

  • You are competent to report your own medication use. Lay testimony about what you took, how much, and for how long is evidence. It is not automatically discounted because a pharmacy record does not corroborate it.
  • Look for the recommendation rather than the prescription. Providers routinely write "continue OTC NSAIDs as needed," "take ibuprofen 600 mg three times daily," or "advised Aleve for flares." That is documentation that the treatment was clinically directed, even when nothing was dispensed.
  • The intake forms are a record. Medication reconciliation lists at nearly every visit — VA and private — often list over-the-counter drugs the progress note never mentions. So do pre-operative histories and emergency department triage notes.
  • Look for what was prescribed alongside it. A veteran told to take ibuprofen and simultaneously started on famotidine or omeprazole is a veteran whose provider was already worried about the gastrointestinal effect. That is contemporaneous evidence of both the exposure and the concern.
  • A consistent statement, written once and not contradicted, is worth more than a detailed one written late. Say what you remember, plainly, and do not reconstruct dates you do not have.

Competing causes

What if I have other reflux risk factors?

You almost certainly do, and an opinion that pretends otherwise is not credible.

Obesity, hiatal hernia, smoking, alcohol, diet, age, male sex, and other medications all raise the risk of reflux disease and esophagitis. In the endoscopic study cited above, hiatal hernia carried more than three times the odds and obesity was a strong independent factor — larger effects than NSAIDs produced in that same analysis. Any examiner reviewing the file will see these, and if the opinion has not addressed them, the examiner will conclude they explain everything.

The right response is not to minimize them. It is to weigh them:

  • A contributing cause does not have to be the only cause, or even the largest one, for secondary service connection to apply.
  • Several of these risk factors are themselves connected to the rated disability. A veteran whose service-connected spine condition ended their ability to exercise, who gained fifty pounds over the following decade, has a weight problem that runs back to the same disability rather than away from it.
  • Where the competing factors were already present, that is not a defect in the claim. It is the setup for the aggravation argument — a susceptible esophagus is exactly the esophagus in which NSAID injury matters most.

Naming the competing causes and explaining their relative weight is what separates a medical opinion from advocacy, and it is what an examiner engaging with conflicting evidence is supposed to do under McCray v. Wilkie.

A common denial

What if the VA says NSAIDs cause gastritis, not GERD?

This is a real objection and it appears in negative C&P opinions regularly, usually phrased as: NSAIDs are known to cause gastric irritation and ulcers, the medical literature does not establish that NSAIDs cause gastroesophageal reflux disease, therefore the claimed condition is less likely than not related to medication.

The first half of that is correct. The conclusion does not follow from it, for three reasons.

It answers a question about causation with silence about aggravation

Whether NSAIDs generate reflux in a normal esophagus and whether they worsen reflux in an abnormal one are separate questions with separate evidence, and § 3.310(b) makes the second one independently sufficient. An examiner who addresses only the first has left the second unexamined.

It skips the esophageal evidence

The literature on NSAIDs and the esophagus specifically — pill-induced esophagitis, impaired esophageal barrier function, the additive injury of drug plus acid, and the association with reflux esophagitis on endoscopy — is a separate body of work from the gastric ulcer literature. Citing the stomach findings and stopping there is an incomplete review, not a negative one.

It frequently misstates the diagnosis at issue

Many of these veterans do not have uncomplicated heartburn. They have documented esophagitis, erosions, ulceration, or stricture on endoscopy. That is not a symptom complaint. It is mucosal injury, and mucosal injury is precisely what NSAIDs are best established to cause.

A denial resting on that reasoning is a candidate for a rebuttal opinion that engages it directly rather than restating the original argument more loudly. If you have already been denied, bring the denial itself to the consultation — the language the examiner used determines what the next opinion has to do. See denied VA claims.

Specific pathways

Which service-connected conditions most often lead here?

Back, neck, and joint conditions

The largest group by a wide margin. Degenerative disc disease, lumbar or cervical strain, knee and shoulder disabilities, and degenerative arthritis are the conditions for which long-term anti-inflammatory therapy is standard care. Where the VA rated the condition, the VA has documented the need for the treatment.

Migraine and headache disorders

A distinct and often-missed pathway. Veterans with service-connected migraines frequently use ibuprofen, naproxen, or combination analgesics at high doses during attacks, sometimes for years, and often entirely over the counter. The exposure pattern is intermittent but intense, and it is rarely captured anywhere in the pharmacy record.

Inflammatory and autoimmune arthritis

Rheumatoid arthritis, ankylosing spondylitis, gout, and reactive arthritis involve some of the longest and highest-dose NSAID exposures in medicine.

Post-surgical and post-traumatic pain

Where surgery for a service-connected injury was followed by extended anti-inflammatory management.

You do not need a different theory for each joint. The pathway is the same one; what changes is the specific treatment history in your record.

Building the claim

What does the record have to show?

  1. 1

    The underlying condition is service-connected

    The rating decision granting it. Without an established anchor disability there is no secondary claim, only a direct one — a different argument entirely.

  2. 2

    The NSAID exposure, with dose and duration

    VA and private pharmacy records, medication reconciliation lists, provider recommendations for over-the-counter use, and your own statement covering what the records missed. Duration is the center of this claim.

  3. 3

    Why the medication was necessary

    Orthopedic, pain management, physical therapy, and primary care notes documenting the severity of the rated condition and the treatment decisions that followed from it. This is the section a pain medicine physician can develop and a gastroenterology-only review generally cannot.

  4. 4

    The reflux diagnosis and when it started

    Primary care and gastroenterology notes, the date antacids or acid-suppressing medication first appeared, and any change in dose or agent over time. An escalation from occasional famotidine to twice-daily proton pump inhibitor is itself evidence of progression.

  5. 5

    Endoscopy, if you have had one

    The highest-value document in the file. EGD reports establish esophagitis and its grade, erosions, ulceration, stricture, hiatal hernia, and Barrett's esophagus. It is what converts a symptom claim into a documented mucosal injury claim, and it is also what the current evaluation criteria are built around.

  6. 6

    Any prior C&P examination or denial

    This tells the next opinion what it has to answer.

  7. 7

    Competing risk factors, named

    Weight history, smoking, alcohol, hiatal hernia, and other medications. Identified and weighed, not omitted.

On aggravation: many veterans had intermittent heartburn before the NSAIDs and persistent, treatment-requiring reflux disease afterward. That is a claim under 38 C.F.R. § 3.310(b) and Allen v. Brown, 7 Vet. App. 439 (1995), and it belongs in the same opinion as causation rather than in place of it.

Not sure whether your record supports this?

Send the rating decision, your medication list, and any endoscopy report. You will get a direct answer about whether the pathway fits — including if the answer is that it does not.

Evaluation

How does the VA rate GERD now?

Getting GERD service-connected and getting a compensable evaluation for it are two separate questions. A great deal of what is online about this is out of date, and veterans are being told to expect ratings that the current schedule does not provide.

Effective May 19, 2024, GERD received its own diagnostic code for the first time. It is no longer rated by analogy to hiatal hernia under DC 7346. It is rated under 38 C.F.R. § 4.114, Diagnostic Code 7206, and the criteria are built almost entirely around esophageal stricture and dysphagia:

EvaluationCriteria
80%Documented history of recurrent or refractory esophageal stricture causing dysphagia, with aspiration, undernutrition, or substantial weight loss under § 4.112(a), and treatment with either surgical correction of the stricture or a PEG tube
50%Documented history of recurrent or refractory esophageal stricture causing dysphagia requiring dilatation three or more times per year, dilatation with steroids at least once per year, or esophageal stent placement
30%Documented history of recurrent esophageal stricture causing dysphagia requiring dilatation no more than twice per year
10%Documented history of esophageal stricture requiring daily medication to control dysphagia, otherwise asymptomatic
0%Documented history without daily symptoms or the need for daily medication

Read that carefully, because it is the single most important thing on this page for setting expectations. Under DC 7206, daily heartburn controlled by a proton pump inhibitor does not by itself reach 10 percent. The compensable levels require documented esophageal stricture. The maximum went up — 60 percent under the old criteria, 80 percent now — but the path to any compensable evaluation narrowed considerably.

Two consequences follow, and they run in opposite directions.

The first is a caution. A veteran with well-controlled reflux and no endoscopic findings may win service connection and receive 0 percent. That is a real outcome and it should be understood before filing, not after. A 0 percent evaluation is not worthless — it establishes service connection, which matters for future increases if the condition progresses, for treatment access, and as an anchor for further secondary claims — but it is not compensation.

The second is the reason the mechanism section above matters so much. The current criteria pay for stricture. Stricture develops from repeated mucosal injury, ulceration, and healing with fibrosis. NSAID-associated esophageal injury is a stricture mechanism. The veterans most likely to reach a compensable evaluation under DC 7206 are, disproportionately, the ones with an injury history — which is exactly the population this claim describes.

Where a hiatal hernia or another digestive diagnosis is also present, note that § 4.114 directs a single evaluation reflecting the predominant disability picture rather than separate ratings stacked together. Which code produces the better evaluation is a question worth asking before you file rather than after the decision arrives.

FAQ

Common questions about GERD secondary to NSAIDs

Can GERD be service-connected secondary to a back or knee condition?

Frequently, through the treatment rather than the injury. Under 38 C.F.R. § 3.310, a disability caused or aggravated by treatment for a service-connected condition can itself be service-connected. Where NSAIDs prescribed for a rated spine or joint disability caused esophageal injury or worsened existing reflux, the chain runs back to service. The rating decision granting the underlying condition is itself the VA's documentation that the treatment was medically necessary.

Do NSAIDs cause GERD?

The honest answer is more specific than yes or no. Observational studies consistently associate NSAID use with reflux symptoms and with reflux esophagitis on endoscopy, independent of obesity, hiatal hernia, smoking, and alcohol. But a controlled study in healthy volunteers found that naproxen did not create reflux or weaken the lower esophageal sphincter in people with normal esophageal function. The evidence fits best with NSAIDs injuring the esophageal lining and worsening reflux in people already susceptible to it, rather than generating reflux from nothing. That distinction is why aggravation is often the stronger theory in these claims.

I had heartburn before I ever took NSAIDs. Can I still claim?

Yes, as aggravation rather than causation. Under 38 C.F.R. § 3.310(b) and Allen v. Brown, a service-connected disability that worsens another condition beyond its natural progression supports compensation for the degree of aggravation. Occasional heartburn before long-term NSAID therapy and persistent, treatment-requiring reflux disease afterward is the exact pattern that theory addresses. Where the record supports both theories, both should be argued.

My ibuprofen was over the counter and isn't in my VA pharmacy record. Is the claim dead?

Usually not. You are competent to report your own medication use, and lay testimony is evidence. Beyond that, look for provider notes recommending over-the-counter NSAIDs, medication reconciliation lists from routine visits, pre-operative and emergency department histories, and any acid-reducing medication started around the same time. Absence from a pharmacy record is not the same thing as absence of exposure.

Which NSAIDs count for this claim?

All of the common ones carry the mechanism — ibuprofen, naproxen, meloxicam, diclofenac, indomethacin, celecoxib, and aspirin. Dose, duration, and medical necessity matter more than which drug appears in the chart. Two distinctions are worth making honestly: celecoxib is COX-2 selective with a different upper-gastrointestinal risk profile, and low-dose aspirin taken for cardiac prophylaxis is a different exposure from analgesic-dose aspirin.

The C&P examiner said NSAIDs cause gastritis, not GERD. What now?

That reasoning is incomplete rather than wrong. It answers a causation question while leaving aggravation unaddressed, it cites the gastric ulcer literature while omitting the separate body of evidence on NSAIDs and the esophagus, and it often does not engage with what the veteran's endoscopy actually showed. A rebuttal opinion has to address that specific reasoning directly. Bring the denial language to the consultation.

Should I stop taking NSAIDs to strengthen my claim?

No. Do not start, stop, or change any medication because of a VA claim. The condition being treated is one the VA has already recognized as disabling, and stopping an aspirin prescribed for cardiac reasons carries real risk. If you are concerned about gastrointestinal effects, that is a conversation with your prescriber, who has options including acid suppression, dose adjustment, and alternative agents. Claims are built from the record as it exists.

What is the current VA rating for GERD?

Since May 19, 2024, GERD is rated under 38 C.F.R. § 4.114, Diagnostic Code 7206, at 0, 10, 30, 50, or 80 percent. It is no longer rated by analogy to hiatal hernia under DC 7346, and much of what remains online quotes the old criteria. Every compensable level under DC 7206 requires documented esophageal stricture. Daily reflux symptoms controlled with medication, without stricture, generally fall at 0 percent.

Is it worth filing if I might only get 0 percent?

That depends on your record and your goals. A 0 percent evaluation still establishes service connection, which preserves the effective date, supports an increase if the condition progresses, and can anchor further secondary claims. But if there is no endoscopy in your file and no stricture, a compensable evaluation is unlikely under the current criteria, and it is better to know that before spending money on an opinion. That is one of the things a consultation is for.

Which physician should write my opinion?

Where the service-connected condition is musculoskeletal, orthopedic, neurologic, or a headache disorder and the medication is an anti-inflammatory or analgesic, Dr. Robert J. Allen is the fit. Where the anchor condition is psychiatric or the medication at issue is a psychotropic, Dr. Jessica R. Allen is. Files spanning both are common, and the consultation will sort out which your case needs — including if the answer is that you do not need an opinion at all.

Brightview Psychiatry Solutions PLLC provides independent medical opinions and psychiatric evaluations. This page is educational and is not medical or legal advice, and does not create a physician-patient relationship. VA determines service connection and assigns all disability evaluations. No outcome is guaranteed.

Book a Consultation